NURS 571 FINAL EXAM WITH CORRECT
QUESTIONS AND ANSWERS 2025
COPD is airflow limitation that is not fully reversible
t/f - CORRECT-ANSWERSTrue
__________ is characterized by reversible airflow obstruction - CORRECT-
ANSWERSAsthma
Destruction and permanent enlargement of airspaces distal to terminal
bronchioles characterized by destruction of alveoli without obvious fibrosis
and hyperinflation/air trapping is known as:
A. COPD
B. Asthma
C. Chronic Bronchitis
D. Emphysema - CORRECT-ANSWERSD. Emphysema
Sputum production daily for 3 or more months for 2 or more years is
characteristic of _________________ - CORRECT-ANSWERSChronic Bronchitis
Smoking> 30 years
Chronic coughing
excessive sputum production
4th and 5th decade of life
Genetic component
Are characteristics of what? - CORRECT-ANSWERSTypical COPD patient
,Stage 1: Mild
A. FEV1/FVC <70%, FEV1> 80%
B.FEV1/FVC <70%, FEV1 50-79%
C.FEV1/FVC <70%, FEV1 30-49% with or w/o sx
D.FEV1/FVC <70%, FEV1 <30% or <50% with resp failure - CORRECT-
ANSWERSA
Stage 2: moderate
A. FEV1/FVC <70%, FEV1> 80%
B.FEV1/FVC <70%, FEV1 50-79%
C.FEV1/FVC <70%, FEV1 30-49% with or w/o sx
D.FEV1/FVC <70%, FEV1 <30% or <50% with resp failure - CORRECT-
ANSWERSB
Stage 3: severe
A. FEV1/FVC <70%, FEV1> 80%
B.FEV1/FVC <70%, FEV1 50-79%
C.FEV1/FVC <70%, FEV1 30-49% with or w/o sx
D.FEV1/FVC <70%, FEV1 <30% or <50% with resp failure - CORRECT-
ANSWERSC
Stage 4: very severe
, A. FEV1/FVC <70%, FEV1> 80%
B.FEV1/FVC <70%, FEV1 50-79%
C.FEV1/FVC <70%, FEV1 30-49% with or w/o sx
D.FEV1/FVC <70%, FEV1 <30% or <50% with resp failure - CORRECT-
ANSWERSD
COPD trifecta - CORRECT-ANSWERSIncrease cough, dyspnea, sputum
production
Oxygen SPO2 90-94% or PAO2 50-60 mm Hg
Ipratropium bromide
Beta 2 agonists
Systemic corticosteroids
Antibiotics
NIPPV/chest PT
Are treatments for what? - CORRECT-ANSWERSCOPD exacerbation
Which of the following is NOT a short acting bronchodilator?
A. Albuterol
B. Levalbuterol
C. Salmeterol
D. Metaproterenol
E. Terbutaline - CORRECT-ANSWERSC. Salmeterol is a LABA
Albuterol is the drug of choice if the patient is tachycardic
QUESTIONS AND ANSWERS 2025
COPD is airflow limitation that is not fully reversible
t/f - CORRECT-ANSWERSTrue
__________ is characterized by reversible airflow obstruction - CORRECT-
ANSWERSAsthma
Destruction and permanent enlargement of airspaces distal to terminal
bronchioles characterized by destruction of alveoli without obvious fibrosis
and hyperinflation/air trapping is known as:
A. COPD
B. Asthma
C. Chronic Bronchitis
D. Emphysema - CORRECT-ANSWERSD. Emphysema
Sputum production daily for 3 or more months for 2 or more years is
characteristic of _________________ - CORRECT-ANSWERSChronic Bronchitis
Smoking> 30 years
Chronic coughing
excessive sputum production
4th and 5th decade of life
Genetic component
Are characteristics of what? - CORRECT-ANSWERSTypical COPD patient
,Stage 1: Mild
A. FEV1/FVC <70%, FEV1> 80%
B.FEV1/FVC <70%, FEV1 50-79%
C.FEV1/FVC <70%, FEV1 30-49% with or w/o sx
D.FEV1/FVC <70%, FEV1 <30% or <50% with resp failure - CORRECT-
ANSWERSA
Stage 2: moderate
A. FEV1/FVC <70%, FEV1> 80%
B.FEV1/FVC <70%, FEV1 50-79%
C.FEV1/FVC <70%, FEV1 30-49% with or w/o sx
D.FEV1/FVC <70%, FEV1 <30% or <50% with resp failure - CORRECT-
ANSWERSB
Stage 3: severe
A. FEV1/FVC <70%, FEV1> 80%
B.FEV1/FVC <70%, FEV1 50-79%
C.FEV1/FVC <70%, FEV1 30-49% with or w/o sx
D.FEV1/FVC <70%, FEV1 <30% or <50% with resp failure - CORRECT-
ANSWERSC
Stage 4: very severe
, A. FEV1/FVC <70%, FEV1> 80%
B.FEV1/FVC <70%, FEV1 50-79%
C.FEV1/FVC <70%, FEV1 30-49% with or w/o sx
D.FEV1/FVC <70%, FEV1 <30% or <50% with resp failure - CORRECT-
ANSWERSD
COPD trifecta - CORRECT-ANSWERSIncrease cough, dyspnea, sputum
production
Oxygen SPO2 90-94% or PAO2 50-60 mm Hg
Ipratropium bromide
Beta 2 agonists
Systemic corticosteroids
Antibiotics
NIPPV/chest PT
Are treatments for what? - CORRECT-ANSWERSCOPD exacerbation
Which of the following is NOT a short acting bronchodilator?
A. Albuterol
B. Levalbuterol
C. Salmeterol
D. Metaproterenol
E. Terbutaline - CORRECT-ANSWERSC. Salmeterol is a LABA
Albuterol is the drug of choice if the patient is tachycardic
